Fujifilm and Taisho complete Toyama acquisition
This article was originally published in Scrip
Fujifilm Holdings and Taisho have taken the final step in a series of transactions which have given Fujifilm a two-thirds holding in the mid-sized firm Toyama Chemical. Fujifilm acquired the antibiotics specialist earlier this year via a tender offer and share purchase agreement announced in February (Scrip Online, February 15th, 2008). Toyama was delisted in August. Fujifilm has now transferred 34% of Toyama to Taisho, raising its previous 22% stake in the company. Taisho will book a one-off gain of around ¥1.8 billion ($18.4 million) in relation to the transaction.
You may also be interested in...
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Plus deals involving Takeda/OrigiMed, Amcure/Hinova, AUM/Newsoara, Taiho/Lung Therapeutics, 3D Medicines/Aravive, HitGen/Baiyunshan, Dong-A/Jiangsu Hengrui, and Crescita/Juyou.